🇺🇸 AMGN — Amgen Inc.

Healthcare Compra
← Volver

Precio actual

437,23 USD

Máx. histórico

447,03

10 días

Split 2:1 del 22/11/1999

Caída desde máximo

-2,19%

Rango 52 semanas

269,77 – 447,03

Variación hoy

-1,55%

Cierre anterior

444,12

Rango de hoy

435,01 – 441,66

Volumen hoy

1.656.089

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
27,17 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
389,69 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 3 días
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,27%
Fecha de pago Importe por participación
16/08/2011 0,2800 USD
Splits Registrados en el histórico de precios
Fecha Ratio
22/11/1999 2:1
01/03/1999 2:1
16/08/1995 2:1
11/09/1991 3:1
13/08/1990 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
11/11/2014 163,08 163,86 161,52 162,42 -0,41% 1,43% 3.015.700
10/11/2014 161,01 163,20 160,50 163,09 +1,77% 1,68% 3.160.900
07/11/2014 162,07 162,25 158,32 160,25 -0,06% 2,42% 3.633.300
06/11/2014 159,97 160,94 159,47 160,35 +0,89% 0,92% 3.310.900
05/11/2014 161,31 161,31 158,81 158,94 -0,92% 1,55% 4.062.900
04/11/2014 160,69 161,99 159,17 160,41 -0,71% 1,75% 3.719.000
03/11/2014 162,08 162,41 159,65 161,56 -0,38% 1,70% 5.823.800
31/10/2014 164,56 164,65 161,42 162,18 +0,37% 1,96% 7.971.100
30/10/2014 158,64 161,58 158,16 161,58 +1,70% 2,16% 3.864.500
29/10/2014 157,91 159,72 156,91 158,88 +1,08% 1,78% 7.069.800
28/10/2014 151,75 157,25 151,47 157,19 +6,07% 3,81% 11.623.200
27/10/2014 146,70 148,47 146,11 148,20 +0,64% 1,61% 4.172.500
24/10/2014 146,85 147,50 145,52 147,26 +0,01% 1,35% 5.318.400
23/10/2014 145,90 148,14 145,24 147,25 +2,51% 1,99% 4.710.700
22/10/2014 143,81 144,41 141,67 143,64 -0,31% 1,91% 5.222.100
21/10/2014 138,49 145,49 137,01 144,09 +4,79% 6,12% 8.951.400
20/10/2014 133,28 137,55 133,01 137,51 +2,86% 3,41% 6.623.800
17/10/2014 131,25 139,85 129,50 133,69 +2,48% 7,89% 7.351.500
16/10/2014 128,15 130,88 127,67 130,45 -0,34% 2,50% 7.906.000
15/10/2014 131,02 131,37 128,60 130,90 -0,98% 2,11% 4.700.100
14/10/2014 135,38 135,43 131,93 132,20 -1,02% 2,59% 3.736.400
13/10/2014 137,05 137,81 133,52 133,56 -2,79% 3,13% 6.866.700
10/10/2014 136,78 140,74 136,78 137,39 -0,14% 2,90% 5.750.400
09/10/2014 139,57 140,19 137,02 137,58 -1,78% 2,27% 2.750.500
08/10/2014 135,61 140,38 135,42 140,07 +2,97% 3,66% 3.621.000
07/10/2014 137,14 137,54 135,98 136,03 -1,15% 1,14% 2.679.500
06/10/2014 138,07 140,55 136,98 137,61 -1,11% 2,59% 3.190.200
03/10/2014 138,07 139,71 137,90 139,15 +1,42% 1,31% 3.429.000
02/10/2014 138,98 139,77 136,32 137,20 -1,17% 2,48% 3.060.900
01/10/2014 140,39 140,78 138,18 138,82 -1,17% 1,85% 3.752.200